Home » Newsletters » BioWorld Science

BioWorld Science

April 30, 2007

View Archived Issues

Recent patents describe new analgesic agents

Novel treatments for immunological diseases claimed in recent patent literature

Fresenius Kabi to acquire Kyorin's blood volume replacement business

Novel therapeutic strategies for cancer covered in recent patent literature

Targeting the sodium pump alpha1 subunit shows promising results in NSCLC

Preclinical profile of the c-Met inhibitor ARQ-197 reported by ArQule

Novel c-Met inhibitor presented at the AACR meeting

New somatostatin receptor ligand shows antitumor activity in vivo

Vascular disrupting activity of MPC-6827 alone or in combination with carboplatin

New Canadian approval for Lipitor

BMS and Pfizer collaborate on anticoagulant and metabolic compounds

FDA approves IND for M6G

Lexicon Genetics changes name to Lexicon Pharmaceuticals

SB-509 begins new phase II study in moderate to severe diabetic neuropathy

Nuvion advanced into second pivotal study in steroid-refractory ulcerative colitis

Novagali cleared to begin U.S. phase III study of Nova-22007

Prochieve shows possible effect in delaying cervical shortening

Humira recommended for E.U. approval for Crohn's disease

Invega recommended for European approval

New approvable letter for CIP-Isotretinoin

U.K. launch for Prezista

Byetta launched in U.K.

Januvia launched in U.K.

Advagraf receives E.U. approval

Non-approvable letter for Arcoxia

Novartis' Optaflu recommended for E.U. approval

CHMP hands down negative opinion on Genasense for melanoma

Novel Amgen c-Met inhibitors reported to be active against multiple mutations

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...